Wobble Genomics Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Wobble Genomics Limited - overview
Established
2020
Location
Edinburgh, -, UK
Primary Industry
Biotechnology
About
Based in Edinburgh, UK, and founded in 2020, Wobble Genomics Limited provides integrated solution for RNA and DNA sequencing. The company was founded by its CEO Richard Kuo. In September 2021, the firm raised GBP 1. 2 million in Seed funding led by investor Eos Advisory LLP, with participation from another investor Old College Capital.
The round was part of a larger GBP 2. 15 million Seed funding round. The company offers a nucleic acid biomarker which provides integrated solutions to its customers. The firm uses the level-up which is cDNA normalization technology that allows maximum sampling during sequencing as well as works with all current sequencing technologies.
Additionally, the firm technology includes a software package known as TAMA which helps in analyzing long read RNA sequencing data.
Current Investors
Old College Capital, Eos , Mercia Asset Management
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.wobblegenomics.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.